EIF4A inhibition targets bioenergetic homeostasis in AML and synergizes with cytarabine and venetoclax

Katie Fooks(Jewish General Hospital), François Mercier(Jewish General Hospital)

Research Square

June 22, 2022

10.21203/rs.3.rs-1696855/v1

Cited by 0

Related Papers

EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax

|Journal of Experimental & Clinical Cancer Research|2022|35

Common clonal origin of chronic myelomonocytic leukemia and B-cell acute lymphoblastic leukemia in a patient with a germline <i>CHEK2</i> variant

|Molecular Case Studies|2021|8